Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs

Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
Drug Metabolism and Disposition December 1999, 27 (12) 1512-1518;
Vinayak P. Hosagrahara
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda K. Hansen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rory P. Remmel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The induction of putative CYP3A isoforms in cultured porcine hepatocytes was evaluated by measurement of midazolam metabolism, a model substrate of the CYP3A family. The induction was also studied at the molecular level by quantitation of mRNA and protein levels, by Northern blotting and Western blotting, respectively. Pretreatment with rifampin (50 μM) resulted in a 5.5- to 9-fold higher rate of midazolam metabolism when compared with control cultures. No induction was observed when the cultures were pretreated with 50 μM dexamethasone. A 12-fold increase in the CYP3A mRNA signal (∼2.4 kB) was observed in induced cultures over control cultures. Microsomal proteins were separated by SDS-polyacrylamide gel electrophoresis and detected by immunoblotting with a polyclonal antibody raised against human CYP3A4. The immunoblots showed the presence of four bands in microsomes prepared from pig livers, with two bands (51.5 and 52 kD) that showed intense staining. Microsomes prepared from a pig pretreated with rifampin showed marked induction of these two bands. Immunoblotting of microsomes from rifampin-induced cultures also showed significantly greater intensity than in control cultures. Our results indicate that rifampin, but not dexamethasone, is an inducer of midazolam hydroxylase in pig hepatocytes. This induction may be regulated at the transcriptional level as detected by an increase in mRNA with a CYP3A oligonucleotide probe. Finally, there appears to be a multiplicity of the CYP3A isoforms in pig hepatocytes, similar to that observed in humans and rats.

Footnotes

  • Send reprint requests to: Dr. Rory P. Remmel, Department of Medicinal Chemistry, University of Minnesota, 8–101 Weaver-Densford Hall, 308 Harvard St. S.E., Minneapolis, MN 55455. E-mail:remme001{at}tc.umn.edu

  • ↵1 These results were in partial fulfillment of the doctoral degree requirements of V.H. Preliminary results were reported at the 8th North American ISSX Meeting, Oct, 26–30, 1997, Hilton Head, NC.

  • ↵2 Present address: Bristol Myers Squibb, P.O. Box 4000, F13–02, Princeton, NJ 08543.

  • This work was supported by the National Institutes of Health Grant R01 DK45371–02.

  • Abbreviations used are::
    P-450
    cytochrome P-450
    MDZ
    midazolam
    1′-OH MDZ
    1′-hydroxymidazolam
    4-OH MDZ
    4-hydroxymidazolam
    1′,4-diOH MDZ
    1′,4-dihydroxymidazolam
    SSC
    saturated sodium citrate
    DMSO
    dimethyl sulfoxide
    • Received June 7, 1999.
    • Accepted September 21, 1999.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 27 (12)
Drug Metabolism and Disposition
Vol. 27, Issue 12
1 Dec 1999
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs

Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
Drug Metabolism and Disposition December 1, 1999, 27 (12) 1512-1518;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Induction of the Metabolism of Midazolam by Rifampin in Cultured Porcine Hepatocytes: Preliminary Evidence for CYP3A Isoforms in Pigs

Vinayak P. Hosagrahara, Linda K. Hansen and Rory P. Remmel
Drug Metabolism and Disposition December 1, 1999, 27 (12) 1512-1518;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Humanized PXR-CAR-CYP3A4/7 Mouse as Model of Induction
  • Ozanimod Human Metabolism and Disposition
  • High-Throughput Characterization of SLCO1B1 VUS
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics